Shearman & Sterling advised Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Bank PLC and J.P. Morgan Securities LLC as joint lead arrangers and joint bookrunning managers in connection with a $5 billion term loan related to Amgen Inc.’s $10.5 billion purchase of Onyx Pharmaceuticals Inc. Concurrently, the firm also represented Bank of America, N.A. in connection with a $3.1 billion sale and repurchase agreement financing transaction related to the acquisition.

More >>

Arnold & Porter LLP announced today that Virginia Murphy has joined the firm’s Business Litigation practice in its New York office as counsel. Ms. Murphy hails from a corporate background that includes providing legal and policy direction to global companies and other organizations on compliance and regulatory issues in the United States and Europe.

More >>

The Firm recently represented Peabody Energy Corporation (Peabody) in a new senior secured credit facility led by Citigroup Global Markets, Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, BNP Paribas Securities Corp., Credit Agricole Corporate and Investment Bank, HSBC Securities (USA) Inc., Morgan Stanley Senior Funding, Inc., PNC Capital Markets LLC and RBS Securities Inc.  The new facility includes a $1.65 billion revolver and a $1.2 billion term loan and replaced Peabody’s existing credit facilities.

More >>

The Firm represented Deutsche Bank Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, RBS Securities Inc., Credit Suisse Securities (USA) LLC, HSBC Securities (USA) Inc., Wells Fargo Securities, LLC and other underwriters in connection with a $1.75 billion offering of debt securities by Wal-Mart Stores, Inc.

More >>

The Firm represented Barclays, BMO Capital Markets, Credit Suisse, CIBC, RBC Capital Markets, Morgan Stanley, HSBC Securities, J.P. Morgan and TD Securities as initial purchasers in connection with a 144A/Regulation S offering by MEG Energy Corp. (“MEG”) of $800 million of 7.0% Senior Notes due 2024.  MEG intends to use the net proceeds from the offering for general corporate purposes, including funding its 2014 capital program.

More >>